Status
Conditions
Treatments
About
Purpose to evaluate the effects of topical tranexamic acid (TA) on reducing post-partum hemorrhage in pregnant women with hemorrhagic cesarean section
Full description
Uterine atony is the major cause of postpartum hemorrhage (PPH), accounting for up to 80% of PPH cases. PPH is the leading cause of maternal morbidity and mortality worldwide, resulting in up to 28% of maternal deaths. Therefore, inducing a rapid and effective uterine contraction following delivery is an important issue. The aim of the study is to To explore the efficacy and safety of temporary uterine packing combined with topical tranexamic acid (TA) as an adjunct for reducing blood loss during a hemorrhagic cesarean delivery (CD), compared with placebo.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
placenta praevia and placental abruption
Women with a medical disorder,
placenta accrete,
allergy to TA, and
intraoperative bleeding thanks to causes aside from uterine atony
Patients over 40 or who have
with a severe medical disorder
allergy to tranexamic acid
refuse to consent
Primary purpose
Allocation
Interventional model
Masking
180 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal